Can primaquine therapy for vivax malaria be improved?
The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...
المؤلفون الرئيسيون: | Baird, J, Rieckmann, K |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2003
|
مواد مشابهة
-
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
حسب: Baird, J
منشور في: (2018) -
Primaquine as anti-relapse therapy for Plasmodium vivax
حسب: Baird, J
منشور في: (1998) -
Primaquine therapy for malaria.
حسب: Baird, J, وآخرون
منشور في: (2004) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
حسب: Krudsood, S, وآخرون
منشور في: (2008) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
حسب: Luzzi, G, وآخرون
منشور في: (1992)